Coty Inc. Form 10-Q Summary
Period: The filing covers the quarter and nine months ended March 31, 2016, Coty’s fiscal third quarter of fiscal 2016. The request metadata says “2015 Q3,” which does not match the filing period.
Business context and reporting period
Coty manufactures and markets fragrances, color cosmetics, and skin and body care products in more than 130 countries. Its fiscal year ends June 30, and results are seasonal, with holiday-related demand typically increasing in the second fiscal quarter. In February 2016, Coty acquired the Brazilian Beauty Business, which began reporting as a separate segment.
Key financial metrics
| Metric | Three months ended March 31, 2016 | Three months ended March 31, 2015 | Nine months ended March 31, 2016 | Nine months ended March 31, 2015 |
|---|---|---|---|---|
| Net revenue | $950.7 million | $933.8 million | $3,273.5 million | $3,375.7 million |
| Gross profit | $581.7 million | $582.0 million | $1,993.1 million | $2,032.8 million |
| Operating income | $23.0 million | $114.7 million | $257.1 million | $418.5 million |
| Net income (loss) attributable to Coty | $(26.8) million | $75.5 million | $187.9 million | $211.5 million |
| Diluted EPS | $(0.08) | $0.21 | $0.53 | $0.59 |
| Operating cash flow | Not provided for the quarter | Not provided for the quarter | $445.3 million | $388.2 million |
Gross margin was approximately 61.2% for the quarter, compared with 62.3% a year earlier; for the nine-month period it was approximately 60.9%, compared with 60.2%. Operating margin declined to 2.4% from 12.3% for the quarter and to 7.9% from 12.4% for the nine-month period. Company-defined adjusted operating income was $81.7 million for the quarter, down 19%, and $469.7 million for nine months, essentially unchanged. Adjusted net income attributable to Coty was $31.5 million for the quarter, versus $63.6 million, and $387.0 million for nine months, versus $329.8 million; these non-GAAP measures exclude specified items and are not substitutes for GAAP results.
Cash and equivalents were $366.6 million at March 31, 2016, versus $341.3 million at June 30, 2015. Current assets were $1,899.1 million and current liabilities $1,730.2 million. Nine-month capital expenditures were $115.3 million; operating cash flow less capital expenditures was $330.0 million, a simple derived measure. Total debt was $4,136.3 million, versus $2,634.7 million at June 30, 2015. Coty reported compliance with its credit-agreement financial covenants at quarter-end.
Material changes versus the prior comparable period
- Quarterly revenue rose 2%, reflecting 12% unit-volume growth, partly offset by negative price and mix of 7% and foreign-exchange translation of 3%. Excluding acquisitions, discontinued TJoy and currency effects, revenue declined 1%.
- For nine months, revenue fell 3%, primarily from a 7% foreign-exchange impact; excluding acquisition, TJoy and currency effects, revenue declined 1%.
- Color Cosmetics grew, supported by Bourjois and improved price and mix; Fragrances and Skin & Body Care declined. Quarterly segment revenue changed by: Fragrances -4%, Color Cosmetics +11%, and Skin & Body Care -12%.
- Quarterly operating income fell sharply as acquisition-related costs, SG&A, restructuring, and cost of sales increased. Nine-month operating income also declined, despite improved gross margin.
- Nine-month operating cash flow increased, but investing cash outflow rose to $1,042.0 million, mainly due to the $897.3 million net cash payment for the Brazilian acquisition. Financing cash flow was $621.7 million, including substantial borrowing and $727.9 million of treasury-share purchases.
Outlook, management commentary, risks, and unusual items
- Management described difficult market conditions, particularly mass fragrance in Western Europe and the U.S. It emphasized investment in ten “power brands,” portfolio rationalization, geographic expansion, and channel diversification. No specific standalone revenue or earnings guidance is provided in the filing text.
- The Brazilian Beauty Business acquisition had a stated purchase price of $899.0 million. From acquisition through March 31, it contributed $14.3 million of revenue and a $4.4 million net loss; its reported segment operating loss was $6.6 million. Acquisition-related costs were $98.3 million for nine months, and restructuring costs were $79.3 million.
- The planned P&G Beauty Brands transaction was expected to close in the second half of calendar 2016, subject to regulatory and other conditions. Coty estimated transaction value at $13.5 billion, including approximately $11.5 billion in equity and $2.0 billion of assumed debt; P&G shareholders were expected to own about 54% of the combined company. The filing describes a revised estimate of approximately $1.2 billion in one-time charges and $500 million in capital expenditures associated with the transaction and integration.
- The IRS settlement concerning 2004–2012 examinations generated a $193.9 million tax benefit, of which $113.0 million was offset by a valuation allowance. This helped produce a nine-month income-tax benefit of $42.5 million; the quarter itself recorded an $11.6 million tax provision despite a pretax loss.
- Debt was refinanced in October 2015 under secured facilities maturing mainly in 2020 and 2022. Variable-rate debt exposes Coty to interest-rate risk; the company entered into $2.0 billion of interest-rate swaps. On April 8, 2016, it arranged additional euro-denominated term loans, expected to repay revolver balances.
- Unresolved contingencies include a possible U.S. antiboycott penalty related to voluntary disclosures concerning the UAE subsidiary; Coty had not recorded a reserve and said a material loss was reasonably possible. The IPO securities class action was dismissed in full on March 29, 2016, subject to possible appeal.
- Other risks include execution and integration of the P&G transaction, potential tax indemnification obligations and post-merger restrictions, increased leverage, foreign-exchange exposure, weak or changing consumer demand, licensing relationships, and restructuring execution. Management said disclosure controls were effective at the reasonable-assurance level.
Important facts for investors to verify
- Whether underlying demand and margins improve after excluding acquisitions, currency movements, discontinued brands, and unusual costs.
- The final terms, closing conditions, financing, share dilution, assumed debt, and actual integration costs of the P&G transaction.
- Debt levels, interest expense, covenant headroom, and liquidity after subsequent borrowing and transaction-related spending.
- The cash and earnings impact of the Brazilian acquisition, restructuring programs, and the IRS tax settlement, including whether tax benefits recur.
- The outcome and potential exposure from the antiboycott review, and any appeal of the dismissed IPO litigation.